The Medicines and Health products Regulatory Agency (MHRA) has issued a class two medicines recall for Epilim 500mg gastro-resistant tablets (PL 04425/0303) of Sanofi.
Sanofi has informed the MHRA that it is recalling the product batches as a precautionary measure due to out of specification results for disintegration test during routine stability testing.
|Batch Number||Expiry Date||Pack Size||First Distributed|
|R0601||08/2022||30||November 6, 2019|
|R0602||08/2022||30||November 5, 2019|
|R0603||08/2022||30||November 6, 2019|
The healthcare professionals have been advised to stop supplying the product batches immediately and quarantine all stock and return it to their supplier using their supplier’s approved process.